HF
NVAX icon

HRT Financial’s Novavax NVAX Stock Holding History

HRT Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-834,223
Closed -$7.56M – 4431
2025
Q4 		$5.61M Sell
834,223
-411,485
-33% -$3.1M 0.02% 732
2025
Q3 		$10.8M Buy
1,245,708
+630,059
+102% +$4.9M 0.04% 370
2025
Q2 		$3.88M Buy
615,649
+404,676
+192% +$2.68M 0.02% 645
2025
Q1 		$1.35M Buy
+210,973
New +$1.74M 0.01% 989
2023
Q4 		– Sell
-55,332
Closed -$400K – 2850
2023
Q3 		$400K Buy
+55,332
New +$442K ﹤0.01% 1527
2023
Q1 		– Sell
-181,919
Closed -$1.87M – 2972
2022
Q4 		$1.87M Buy
181,919
+121,545
+201% +$2.15M 0.03% 629
2022
Q3 		$1.1M Buy
+60,374
New +$2.62M 0.01% 855
2021
Q3 		– Sell
-109,286
Closed -$24.1M – 3616
2021
Q2 		$23.2M Buy
109,286
+40,042
+58% +$7.34M 0.21% 72
2021
Q1 		$12.6M Buy
+69,244
New +$13.8M 0.13% 106
2020
Q4 		– Sell
-5,093
Closed -$541K – 2269
2020
Q3 		$551K Buy
+5,093
New +$620K 0.02% 833
2020
Q1 		– Sell
-26,985
Closed -$107K – 1176
2019
Q4 		$107K Buy
26,985
+13,556
+101% +$58.8K ﹤0.01% 1025
2019
Q3 		$67K Buy
+13,429
New +$73.5K ﹤0.01% 1283
2019
Q2 		– Sell
-1,705
Closed -$18K – 864
2019
Q1 		$18K Buy
+1,705
New +$53.8K ﹤0.01% 475
2018
Q2 		– Sell
-712
Closed -$29K – 340
2018
Q1 		$29K Sell
712
-231
-24% -$9.28K 0.01% 193
2017
Q4 		$23K Buy
+943
New +$23K 0.02% 112
2015
Q3 		– Sell
-506
Closed -$112K – 155
2015
Q2 		$112K Buy
+506
New +$88.9K 0.05% 151

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's NVAX Position: Q1 2026 in Review

HRT Financial sold out of Novavax (NVAX) in Q1 2026, closing a stake of 834,223 shares — an estimated $7.56M sold.

HRT Financial first reported a position in NVAX in Q2 2015 and held it in 16 quarters. The position peaked at $23.2M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • HRT Financial reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 834,223 Novavax shares in Q1 2026, an estimated $7.56M.
  • HRT Financial first reported a position in Novavax in Q2 2015 and held it in 16 quarters.
  • HRT Financial's Novavax position peaked at $23.2M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.